Notably, in breast cancer, relative low expression of hamartin and tuberin (TSC1 and TSC2 products, respectively) is associated with poor clinical outcome [24], and depletion of tuberin promotes metastasis [25]. The gene discussed is TSC2; the disease is breast carcinoma.